Danaher Corporation $DHR Shares Acquired by Investors Research Corp

Investors Research Corp lifted its holdings in Danaher Corporation (NYSE:DHR) by 189.8% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 8,143 shares of the conglomerate’s stock after purchasing an additional 5,333 shares during the period. Investors Research Corp’s holdings in Danaher were worth $1,804,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of DHR. Benedict Financial Advisors Inc. acquired a new stake in Danaher in the 3rd quarter valued at about $4,579,000. PFW Advisors LLC purchased a new stake in shares of Danaher in the third quarter valued at approximately $1,305,000. American National Bank & Trust increased its holdings in shares of Danaher by 229.2% in the third quarter. American National Bank & Trust now owns 8,835 shares of the conglomerate’s stock valued at $1,957,000 after purchasing an additional 6,151 shares during the last quarter. First Community Trust NA lifted its position in Danaher by 129.9% during the third quarter. First Community Trust NA now owns 708 shares of the conglomerate’s stock worth $157,000 after buying an additional 400 shares in the last quarter. Finally, Congress Asset Management Co. purchased a new stake in Danaher in the 3rd quarter valued at $3,582,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Up 1.5%

Shares of NYSE:DHR traded up $3.24 during midday trading on Wednesday, reaching $218.85. 3,974,091 shares of the company’s stock were exchanged, compared to its average volume of 4,460,003. The stock has a market cap of $153.85 billion, a price-to-earnings ratio of 38.87, a P/E/G ratio of 2.75 and a beta of 0.76. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm’s 50 day simple moving average is $210.01 and its two-hundred day simple moving average is $194.05. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.77 earnings per share. As a group, sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s dividend payout ratio is currently 28.42%.

Wall Street Analyst Weigh In

Several research firms have recently commented on DHR. UBS Group initiated coverage on Danaher in a report on Wednesday, September 9th. They set a “buy” rating and a $250.00 price target on the stock. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, September 16th. Stifel Nicolaus decreased their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. TD Cowen cut their price target on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Finally, Royal Bank Of Canada upped their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $235.23.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.